17-45962362-G-C

Variant summary

Our verdict is Likely benign. The variant received -2 ACMG points: 2P and 4B. PM2BP4_Strong

The NM_001377265.1(MAPT):​c.25G>C​(p.Glu9Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000137 in 1,460,072 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/22 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar. Another variant affecting the same amino acid position, but resulting in a different missense (i.e. E9K) has been classified as Uncertain significance.

Frequency

Genomes: not found (cov: 32)
Exomes 𝑓: 0.0000014 ( 0 hom. )

Consequence

MAPT
NM_001377265.1 missense

Scores

3
16

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.208

Publications

0 publications found
Variant links:
Genes affected
MAPT (HGNC:6893): (microtubule associated protein tau) This gene encodes the microtubule-associated protein tau (MAPT) whose transcript undergoes complex, regulated alternative splicing, giving rise to several mRNA species. MAPT transcripts are differentially expressed in the nervous system, depending on stage of neuronal maturation and neuron type. MAPT gene mutations have been associated with several neurodegenerative disorders such as Alzheimer's disease, Pick's disease, frontotemporal dementia, cortico-basal degeneration and progressive supranuclear palsy. [provided by RefSeq, Jul 2008]
MAPT Gene-Disease associations (from GenCC):
  • Pick disease
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp
  • semantic dementia
    Inheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp
  • supranuclear palsy, progressive, 1
    Inheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp
  • late-onset Parkinson disease
    Inheritance: Unknown, AD Classification: STRONG, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp
  • progressive supranuclear palsy-parkinsonism syndrome
    Inheritance: AR Classification: MODERATE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -2 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.0624263).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
MAPTNM_001377265.1 linkc.25G>C p.Glu9Gln missense_variant Exon 2 of 13 ENST00000262410.10 NP_001364194.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
MAPTENST00000262410.10 linkc.25G>C p.Glu9Gln missense_variant Exon 2 of 13 1 NM_001377265.1 ENSP00000262410.6 A0A7I2PJZ2

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD4 exome
AF:
0.00000137
AC:
2
AN:
1460072
Hom.:
0
Cov.:
33
AF XY:
0.00000138
AC XY:
1
AN XY:
726340
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
33420
American (AMR)
AF:
0.00
AC:
0
AN:
44702
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26132
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39698
South Asian (SAS)
AF:
0.00
AC:
0
AN:
86156
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53410
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
4456
European-Non Finnish (NFE)
AF:
8.99e-7
AC:
1
AN:
1111856
Other (OTH)
AF:
0.0000166
AC:
1
AN:
60242
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Cov.:
32

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.099
BayesDel_addAF
Benign
-0.26
T
BayesDel_noAF
Benign
-0.62
CADD
Benign
13
DANN
Benign
0.96
DEOGEN2
Benign
0.29
T;.;.;.;.;.;.;.;.;T;.;.
Eigen
Benign
-1.1
Eigen_PC
Benign
-1.1
FATHMM_MKL
Benign
0.035
N
LIST_S2
Uncertain
0.94
D;D;D;D;D;D;D;.;.;.;.;.
M_CAP
Benign
0.016
T
MetaRNN
Benign
0.062
T;T;T;T;T;T;T;T;T;T;T;T
MetaSVM
Benign
-0.99
T
MutationAssessor
Benign
0.34
N;N;N;N;N;N;N;N;N;N;N;N
PhyloP100
0.21
PrimateAI
Benign
0.31
T
PROVEAN
Benign
-0.50
N;N;N;N;N;N;N;N;N;.;.;.
REVEL
Benign
0.072
Sift
Uncertain
0.0040
D;D;D;D;D;D;D;D;D;.;.;.
Sift4G
Uncertain
0.029
D;T;D;T;T;D;D;T;D;D;T;T
Polyphen
0.10
B;B;B;.;B;B;B;B;B;B;B;.
Vest4
0.079
MutPred
0.12
Gain of glycosylation at P4 (P = 0.1897);Gain of glycosylation at P4 (P = 0.1897);Gain of glycosylation at P4 (P = 0.1897);Gain of glycosylation at P4 (P = 0.1897);Gain of glycosylation at P4 (P = 0.1897);Gain of glycosylation at P4 (P = 0.1897);Gain of glycosylation at P4 (P = 0.1897);Gain of glycosylation at P4 (P = 0.1897);Gain of glycosylation at P4 (P = 0.1897);Gain of glycosylation at P4 (P = 0.1897);Gain of glycosylation at P4 (P = 0.1897);Gain of glycosylation at P4 (P = 0.1897);
MVP
0.66
MPC
0.18
ClinPred
0.13
T
GERP RS
-1.2
PromoterAI
-0.030
Neutral
Varity_R
0.068
gMVP
0.074
Mutation Taster
=98/2
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs762595428; hg19: chr17-44039728; API